Literature DB >> 8634828

Inhibition of rat liver mitochondrial monoamine oxidase by hydrazine-thiazole derivatives: structure-activity relationships.

G Raciti1, P Mazzone, A Raudino, G Mazzone, A Cambria.   

Abstract

The purpose of this research is to study the relationship between chemical structure and inhibitory activity of some hydrazine-thiazole derivatives on rat liver mitochondria monoamine oxidase (MAO). Forty-five compounds belonging to three series of hydrazine-thiazole derivatives, with either alkylic or arylic substituents in the thiazole ring, were tested. The highest inhibitory activity was observed with piperonyl derivatives 25 and 40, which contain a 4-methyl group in the thiazole nucleus. The structure-activity relationship of MAO inhibitors was established in relation to hydrophobic, electronic and steric hindrance parameters. A mechanism of enzyme inhibition was proposed based on the calculation of HOMO energies.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8634828     DOI: 10.1016/0968-0896(95)00137-6

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  3 in total

Review 1.  Tau as a therapeutic target in neurodegenerative disease.

Authors:  Diana S Himmelstein; Sarah M Ward; Jody K Lancia; Kristina R Patterson; Lester I Binder
Journal:  Pharmacol Ther       Date:  2012-07-10       Impact factor: 12.310

2.  Remodelin Is a Cryptic Assay Interference Chemotype That Does Not Inhibit NAT10-Dependent Cytidine Acetylation.

Authors:  Jonathan H Shrimp; Yihang Jing; Supuni Thalalla Gamage; Kathryn M Nelson; Joseph Han; Keri M Bryson; David C Montgomery; Justin M Thomas; Kellie D Nance; Sunny Sharma; Stephen D Fox; Thorkell Andressen; Wilson R Sinclair; Hong Wu; Abdellah Allali-Hassani; Guillermo Senisterra; Masoud Vedadi; Denis Lafontaine; Jayme L Dahlin; Ronen Marmorstein; Michael A Walters; Jordan L Meier
Journal:  ACS Med Chem Lett       Date:  2020-07-27       Impact factor: 4.632

3.  Design, Synthesis, In Vitro and In Silico Studies of New Thiazolylhydrazine-Piperazine Derivatives as Selective MAO-A Inhibitors.

Authors:  Begüm Nurpelin Sağlık; Osman Cebeci; Ulviye Acar Çevik; Derya Osmaniye; Serkan Levent; Betül Kaya Çavuşoğlu; Sinem Ilgın; Yusuf Özkay; Zafer Asım Kaplancıklı
Journal:  Molecules       Date:  2020-09-22       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.